| Circulating cardiovascular microRNAs in critically ill COVID‐19 patients A Garg, B Seeliger, AA Derda, K Xiao, A Gietz, K Scherf, K Sonnenschein, ... European journal of heart failure 23 (3), 468-475, 2021 | 146 | 2021 |
| Between inflammation and thrombosis: endothelial cells in COVID-19 A Birnhuber, E Fliesser, G Gorkiewicz, M Zacharias, B Seeliger, S David, ... European Respiratory Journal 58 (3), 2021 | 137 | 2021 |
| Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis G Emmi, A Bettiol, E Gelain, IM Bajema, A Berti, S Burns, MC Cid, ... Nature Reviews Rheumatology 19 (6), 378-393, 2023 | 132 | 2023 |
| Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study A Bettiol, ML Urban, L Dagna, V Cottin, F Franceschini, S Del Giacco, ... Arthritis & rheumatology 74 (2), 295-306, 2022 | 129 | 2022 |
| Anti-IL-5 therapy in patients with severe eosinophilic asthma–clinical efficacy and possible criteria for treatment response N Drick, B Seeliger, T Welte, J Fuge, H Suhling BMC pulmonary medicine 18, 1-9, 2018 | 124 | 2018 |
| Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? B Seeliger, J Sznajd, JC Robson, A Judge, A Craven, PC Grayson, ... Rheumatology 56 (7), 1154-1161, 2017 | 124 | 2017 |
| Injury to the endothelial glycocalyx in critically ill patients with COVID-19 K Stahl, PA Gronski, Y Kiyan, B Seeliger, A Bertram, T Pape, T Welte, ... American journal of respiratory and critical care medicine 202 (8), 1178-1181, 2020 | 118 | 2020 |
| Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19 F Karagiannis, K Peukert, L Surace, M Michla, F Nikolka, M Fox, P Weiss, ... Nature 609 (7928), 801-807, 2022 | 107 | 2022 |
| Neuro-Sjögren: peripheral neuropathy with limb weakness in Sjögren's syndrome T Seeliger, NK Prenzler, S Gingele, B Seeliger, S Körner, T Thiele, ... Frontiers in Immunology 10, 1600, 2019 | 92 | 2019 |
| Inhibition of caspase-1 with tetracycline ameliorates acute lung injury K Peukert, M Fox, S Schulz, C Feuerborn, S Frede, C Putensen, H Wrigge, ... American journal of respiratory and critical care medicine 204 (1), 53-63, 2021 | 70 | 2021 |
| Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock K Stahl, JJ Schmidt, B Seeliger, BMW Schmidt, T Welte, H Haller, ... Critical care 24, 1-9, 2020 | 64 | 2020 |
| Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19 M Wygrecka, A Birnhuber, B Seeliger, L Michalick, O Pak, AS Schultz, ... Blood advances 6 (3), 1074-1087, 2022 | 54 | 2022 |
| Switch from IL-5 to IL-5-receptor α antibody treatment in severe eosinophilic asthma N Drick, K Milger, B Seeliger, J Fuge, S Korn, R Buhl, M Schuhmann, ... Journal of asthma and allergy, 605-614, 2020 | 49 | 2020 |
| Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure B Seeliger, M Döbler, R Friedrich, K Stahl, C Kühn, J Bauersachs, ... Critical Care 24, 1-11, 2020 | 44 | 2020 |
| Intracranial hemorrhages on extracorporeal membrane oxygenation: differences between COVID-19 and other viral acute respiratory distress syndrome B Seeliger, M Doebler, DA Hofmaenner, PD Wendel-Garcia, ... Critical care medicine 50 (6), e526-e538, 2022 | 40 | 2022 |
| Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial K Stahl, P Wand, B Seeliger, PD Wendel-Garcia, JJ Schmidt, ... Critical care 26 (1), 134, 2022 | 37 | 2022 |
| Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) M Papo, RA Sinico, V Teixeira, N Venhoff, ML Urban, M Iudici, J Mahrhold, ... Rheumatology 60 (9), 4355-4360, 2021 | 36 | 2021 |
| Clinical molecular imaging of pulmonary CXCR4 expression to predict outcome of pirfenidone treatment in idiopathic pulmonary fibrosis T Derlin, B Jaeger, D Jonigk, RM Apel, J Freise, HO Shin, D Weiberg, ... Chest 159 (3), 1094-1106, 2021 | 35 | 2021 |
| The NLRP3-inflammasome-caspase-1 pathway is upregulated in idiopathic pulmonary fibrosis and acute exacerbations and is inducible by apoptotic A549 cells B Jäger, B Seeliger, O Terwolbeck, G Warnecke, T Welte, M Müller, ... Frontiers in Immunology 12, 642855, 2021 | 34 | 2021 |
| The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling M Ackermann, JC Kamp, C Werlein, CL Walsh, H Stark, V Prade, ... EBioMedicine 85, 2022 | 32 | 2022 |
